| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,145 |
22,012 |
$2.84M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,923 |
4,158 |
$1.24M |
| 64483 |
|
1,921 |
1,738 |
$1.13M |
| 64493 |
|
936 |
783 |
$679K |
| 64490 |
|
579 |
504 |
$410K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,401 |
3,015 |
$369K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,498 |
2,325 |
$310K |
| 62321 |
|
532 |
501 |
$232K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
1,571 |
786 |
$229K |
| G0378 |
Hospital observation service, per hour |
4,372 |
1,931 |
$152K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,605 |
1,383 |
$149K |
| 64635 |
|
257 |
202 |
$141K |
| 80053 |
Comprehensive metabolic panel |
12,540 |
11,013 |
$132K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,908 |
6,134 |
$122K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
628 |
245 |
$112K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,113 |
883 |
$109K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
796 |
750 |
$108K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,119 |
1,042 |
$83K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
895 |
834 |
$65K |
| 96401 |
|
160 |
140 |
$39K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
184 |
175 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
156 |
148 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,038 |
10,713 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
273 |
238 |
$23K |
| 84484 |
|
2,066 |
1,033 |
$22K |
| J2357 |
Injection, omalizumab, 5 mg |
14 |
12 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
72 |
64 |
$12K |
| 97597 |
|
609 |
270 |
$10K |
| 64479 |
|
12 |
12 |
$10K |
| 64633 |
|
16 |
12 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,294 |
32,430 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
96 |
41 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,986 |
12,181 |
$7K |
| 83605 |
|
356 |
237 |
$7K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
40 |
36 |
$7K |
| 0002A |
|
101 |
90 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,390 |
2,733 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,446 |
5,695 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
58 |
38 |
$5K |
| 0001A |
|
91 |
87 |
$4K |
| 80320 |
|
27 |
25 |
$3K |
| 73610 |
|
164 |
136 |
$3K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
451 |
370 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,058 |
799 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
39 |
38 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
15 |
$1K |
| 87400 |
|
34 |
17 |
$942.64 |
| 87040 |
|
38 |
14 |
$940.64 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
29 |
13 |
$917.74 |
| 71045 |
Radiologic examination, chest; single view |
1,316 |
1,148 |
$878.34 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,651 |
1,433 |
$824.12 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
25 |
$641.89 |
| 85027 |
|
1,254 |
899 |
$452.01 |
| 64636 |
|
460 |
183 |
$366.11 |
| 64634 |
|
41 |
12 |
$366.11 |
| 85379 |
|
43 |
26 |
$358.72 |
| 83690 |
|
974 |
847 |
$276.80 |
| 81001 |
|
823 |
656 |
$177.50 |
| 64494 |
|
809 |
444 |
$162.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,702 |
6,239 |
$111.94 |
| 82077 |
|
179 |
168 |
$65.04 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
15 |
$41.38 |
| 84703 |
|
159 |
152 |
$36.21 |
| 99152 |
|
813 |
741 |
$20.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
620 |
586 |
$14.99 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,515 |
3,477 |
$4.93 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,164 |
4,530 |
$2.71 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
31,138 |
13,461 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,697 |
2,334 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
2,766 |
2,339 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
287 |
216 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,881 |
1,647 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,312 |
3,325 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
360 |
331 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18 |
15 |
$0.00 |
| 96376 |
|
327 |
140 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
38 |
36 |
$0.00 |
| 64492 |
|
22 |
12 |
$0.00 |
| 64484 |
|
53 |
43 |
$0.00 |
| 64491 |
|
695 |
404 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
75 |
73 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
60 |
54 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
754 |
626 |
$0.00 |
| 81003 |
|
26 |
24 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
112 |
90 |
$0.00 |
| 64495 |
|
20 |
13 |
$0.00 |
| 87634 |
|
14 |
13 |
$0.00 |
| 82248 |
|
13 |
12 |
$0.00 |